April 10 (Bloomberg) -- South Africa’s new state procurement rules for medication will prejudice importers of generic drugs, Business Day reported, citing the National Association of Pharmaceutical Manufacturers.
The list of products designated for preferential procurement from local manufacturers may force small companies that import medication to lay off staff and lose government business, the Johannesburg-based newspaper said, citing Charles Mothata, chief executive officer of the association. About half its members sell generic drugs, mainly imported from India.
The new rules would give local manufacturers greater certainty of a return on their investment in local manufacturing capacity, the newspaper cited Stavros Nicolaou, spokesman for Pharmaceuticals Made in SA, as saying.
To contact the reporter on this story: Jana Marais in Johannesburg at firstname.lastname@example.org
To contact the editor responsible for this story: John Viljoen at email@example.com